![Tsipi Keren-Lehrer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Tsipi Keren-Lehrer formerly worked at Compugen Ltd., as Vice President-Business Development from 2013 to 2018 and BioLineRx Ltd., as Head-Business Development from 2019 to 2024.
Ms. Keren-Lehrer received her undergraduate degree and graduate degree from Tel-Aviv University and Masters Business Admin degree from The Hebrew University of Jerusalem.
Eerdere bekende functies van Tsipi Keren-Lehrer
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOLINERX LTD. | Corporate Officer/Principal | 01-12-2024 |
| COMPUGEN LTD. | Corporate Officer/Principal | 01-11-2018 |
Opleiding van Tsipi Keren-Lehrer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
 BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
Kies MarketScreener 
